Quinn Emanuel is proud to announce that Managing IP Awards 2023 Americas have recognized our attorneys' hard work on the University of California v Broad Institute and selected it as Impact Case of the year. Congratulations!
We secured a pivotal patent ruling for client The Broad Institute, Inc. against the University of California, University of Vienna, and Emmanuelle Charpentier (“CVC”) when the Patent Trial and Appeal Board (“PTAB”) issued an opinion and judgment confirming Broad’s entitlement to foundational patents on the use of CRISPR-Cas9 in eukaryotic cells (including humans and plants). The PTAB further found CVC’s claims to the same invention unpatentable. CVC scientists Jennifer Doudna and Emmanuel Charpentier were awarded the Nobel Prize for CRISPR-Cas9, and CVC contended that they were entitled to patents covering eukaryotic uses. The PTAB disagreed and found in favor of our client.